^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Epi proLung®

    Company:
    Epigenomics
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    Epi proLung is a Liquid biopsy test for lung cancer detection. It is based on a combination of proprietary Epigenomics DNA methylation biomarkers SHOX2 and PTGER4. It is a reflex test that clarifies indeterminate findings will aid in earlier identification of illness, improved outcomes, and lower costs of treatment by reducing unnecessary procedures.
    Cancer:
    Lung Cancer
    Gene:
    PTGER4 (Prostaglandin E Receptor 4), SHOX2 (SHOX Homeobox 2)
    Method:
    Liquid biopsy
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    12/19/17
    LC
    PTGER4
    CE
    SHOX2